Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:37:36 EDT Thu 25 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Z:ABBV
- ABBVIE INC -
http://www.abbvie.com
18:37:36 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
ABBV
- Z
1.1
166.02
·
166.50
1.1
167.25
-0.55
-0.3
5,502.1
914,192
48,242
167.795
169.14
165.59
182.89 130.9601
18:17:22
08:00
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 48242
More trades...
Time ET
Ex
Price
Change
Volume
18:17:22
Z
166.50
-1.30
5
18:10:07
Z
166.49
-1.31
75
18:09:34
Z
166.50
-1.30
1
18:07:30
Z
166.50
-1.30
60
18:05:59
Z
166.50
-1.30
30
18:02:57
Z
166.50
-1.30
25
18:01:34
Z
166.50
-1.30
1
17:57:16
Z
166.50
-1.30
30
17:54:48
Z
166.50
-1.30
5
17:54:18
Z
166.50
-1.30
2
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-25 08:00
U:ABBV
News Release
200
New Data Show RINVOQ(TM) (upadacitinib) Demonstrated Superiority Versus DUPIXENT(TM) (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
2024-04-23 08:00
U:ABBV
News Release
200
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX(TM) Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
2024-04-18 08:31
U:ABBV
News Release
200
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ(TM)) Showed Positive Results in Patients With Giant Cell Arteritis
2024-04-12 07:30
U:ABBV
News Release
200
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA(TM)) for Preventive Treatment of Migraine
2024-04-09 08:00
U:ABBV
News Release
200
SkinMedica(TM) Empowers Clear Skin Confidence with a New, Modern Approach to Acne
2024-04-04 08:00
U:ABBV
News Release
200
AbbVie to Host First-Quarter 2024 Earnings Conference Call
2024-04-03 08:30
U:ABBV
News Release
200
Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting(TM)
2024-04-01 07:50
U:ABBV
News Release
200
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year